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In Brief
Repair of DNA double-strand breaks
(DSBs) by homologous recombination is
activated by the cell cycle kinase Cdk1.
Hentges et al. now find that the NHEJ
factor Xlf1 is phosphorylated by Cdk1 and
that this modification restrains end-
joining in cycling cells. Removal of this
regulation alters DSB pathway selection
in vivo.
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SUMMARY
Eukaryotic cells use two principal mechanisms for
repairing DNA double-strand breaks (DSBs): homolo-
gous recombination (HR) and nonhomologous end-
joining (NHEJ). DSB repair pathway choice is strongly
regulated during the cell cycle. Cyclin-dependent
kinase 1 (Cdk1) activates HR by phosphorylation of
key recombination factors. However, a mechanism
for regulating the NHEJ pathway has not been estab-
lished.Here,we report thatXlf1, a fission yeastXLFor-
tholog, is a key regulator ofNHEJactivity in the cell cy-
cle. We show that Cdk1 phosphorylates residues in
the C terminus of Xlf1 over the course of the cell cycle.
Mutation of these residues leads to the loss of Cdk1
phosphorylation, resulting in elevated levels of NHEJ
repair in vivo. Together, these data establish that
Xlf1 phosphorylation by Cdc2Cdk1 provides amolecu-
lar mechanism for downregulation of NHEJ in fission
yeast and indicates that XLF is a key regulator of
end-joining processes in eukaryotic organisms.
INTRODUCTION
The ability to repair DNA damage is critically important for the
preservation of genomic integrity. DNA double-strand breaks
(DSBs) canbe repairedby twodifferent cellular pathways: homol-
ogous recombination (HR) and nonhomologous end-joining
(NHEJ) (Symington and Gautier, 2011). HR processes use
undamaged homologous DNA sequences—typically from
the sister chromatid—as a repair template, thus enabling error-
free repair. NHEJ can also restore chromosome integrity by
religation of DSB ends (Chiruvella et al., 2013) in the absence of
homologous sequencesbut is potentiallymore error prone.While
core factors such as Ku, XRCC4, XRCC4-like Factor (XLF), and
DNA ligase 4are required for all NHEJ repair reactions, accessory
factors, including polymerases and nucleases, are also needed
to process termini of imprecise DSBs into ligatable substrates.
The relative preference for break repair pathways differs be-
tween eukaryotes. Mammalian cells use NHEJ as the predomi-
nant DSB repair mechanism, where the pathway is available
throughout the cell cycle. Yeast prefer to repair DSBs by HR
(Manolis et al., 2001). Nevertheless, most eukaryotes utilize
both NHEJ and HR; therefore, the choice of repair pathway is
crucial for cell survival. DSB repair pathway selection is regu-
lated in the cell cycle, with NHEJ predominating in G1 phase
and HR restricted to the G2 and S phases of the cell cycle (Fer-
retti et al., 2013). Cyclin-dependent kinase 1 (Cdk1) plays a key
role in regulating end resection during HR. Resection is strongly
inhibited by low Cdk1 activity in G1 and can be reduced in G2 by
Cdk1 inhibition (Aylon et al., 2004; Ira et al., 2004). In mammalian
cells and budding yeast, the main target of CDK phosphorylation
is CtIP/Sae2, which facilitates DSB end resection (Huertas et al.,
2008). Cdk1 phosphorylation also influences later steps in HR, as
well as expression levels of HR proteins.
In budding yeast, the initiation of DSB resection is normally
suppressed in G1 due to low Cdk1 activity and depends on the
MRX complex (Clerici et al., 2008). However, this dependence
on Cdk1 activity can be overcome by deletion of Ku, suggesting
that it induces indirect control over NHEJ by affecting HR
instead. Several potential Cdk1 phosphorylation sites have
been found in budding yeast Ku70/Ku80; however, their muta-
tion did not affect NHEJ activity (Zhang et al., 2009). Thus, direct
Cdk1 targets for NHEJ regulation have not yet been identified. In
fission yeast, there is a reciprocal relationship between the
deployment of the two major DSB pathways with NHEJ func-
tioning during G1 and HR predominant in G2 cells (Ferreira and
Cooper, 2004). It has been proposed that Cdk1 may influence
this pathway selection, but amechanism has not been identified.
Xlf1 is the fission yeast homolog of XLF/Cernunnos (Hentges
et al., 2006; Cavero et al., 2007), a core NHEJ factor that binds
to DNA and stimulates end-joining. In the present study, we iden-
tify Xlf1 as a key regulator of NHEJ activity in the cell cycle. We
report that Cdk1 phosphorylates specific residues in the C termi-
nus of Xlf1 over the course of the cell cycle. Using phospho-null
and phosphomimic mutant strains, we demonstrate that Xlf1
phosphorylation inhibits the NHEJ pathway. We also identify ef-
fects on the checkpoint response and cellular events related to
DSB resection. Together, these data establish that Xlf1 phosphor-
ylation by Cdc2Cdk1 provides a molecular mechanism for the
downregulation of NHEJ in fission yeast and offers insights into
how thispathwaymaybe regulated inother eukaryotic organisms.
RESULTS AND DISCUSSION
Cdk1 Phosphorylates Xlf1 In Vitro
NHEJ is tightly regulated infissionyeast,but themechanism isun-
known (Ferreira andCooper, 2004). To identify if posttranslational
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modifications regulate NHEJ in S. pombe, we analyzed the
sequences of the core factors (Ku, Lig4, and Xlf1). The C-terminal
region of Xlf1 has two sites, T180 and S192, that conform to [ST]-
P-x-[KR], a consensusmotif for phosphorylation by the Cdc2Cdk1
kinase. These potential phosphorylation sites are conserved
in other fission yeasts (Figure 1A). To test if these sites serve as
substrates for Cdc2Cdk1, we mutated them to alanine and per-
formed kinase assays. Wild-type (WT) and mutated Xlf1 proteins
were incubated with mammalian Cdk1 kinase (Figure 1B) or
S. pombe Cdc2Cdk1 complex (Figure 1C). Similarly to histone
H1, a known Cdc2Cdk1 substrate (Moreno et al., 1989), Xlf1 was
phosphorylated, establishing it as an in vitro substrate for the
mammalian and the fission yeast kinase. Phosphorylation of
single point mutants (Xlf1.T180A or Xlf1.S192A) was markedly
reduced compared to WT Xlf1, suggesting that the two sites
can be phosphorylated. When both residues were mutated
to alanine (Xlf1.T180A.S192A or Xlf1.AA), Xlf1 phosphorylation
was abolished. Thus, Cdc2Cdk1 can phosphorylate Xlf1 on two
conserved C-terminal residues in vitro.
Xlf1 Is Phosphorylated by Cdk1 in a
Cell-Cycle-Dependent Manner
Next, we sought to investigate if phosphorylation of Xlf1 occurs
in vivo. While phosphorylation had no apparent effect on the
migration of Xlf1 in standard SDS-PAGE (Figures 1B and 1E),
addition of a phosphate-binding agent, Phos-tag (Kinoshita
et al., 2006), resolved phosphorylated Xlf1 as a distinct band.
GFP-tagged Xlf1 was immunoprecipitated from asynchronous
cultures and analyzed by Phos-tag western blotting. The slower
migrating species was abolished by treatment with lambda
phosphatase (Figure 1D), confirming that this represented phos-
phorylated cellular Xlf1. This species was absent in xlf1.AA, a
strain that expresses Xlf1.AA, regardless of treatment with phos-
phatase. Together, these results demonstrate that Xlf1 is phos-
phorylated at T180 and S192 in vivo and indicate that further
Cdc2Cdk1 kinase sites are unlikely.
To determine if Cdc2Cdk1 is responsible for Xlf1 phosphoryla-
tion in vivo, we used a cdc2-as mutant strain in which we could
inhibit Cdc2Cdk1 activity (Dischinger et al., 2008). Treatment of
cdc2as GFP-xlf1 cultures with the inhibitor (1NM-PP1) caused
a significant reduction of the phosphoband of Xlf1 in Phos-tag
western blots, which could be further reduced by phosphatase
treatment (Figure 1E). This establishes that Xlf1 is phosphory-
lated by Cdc2Cdk1 in unperturbed asynchronous cultures.
Cdc2Cdk1 activity increases from a minimum in G1 to levels
peaking in G2, triggering entry into mitosis. To study changes
in Xlf1 phosphorylation status as cells progressed through the
cell cycle, we used a temperature-sensitive cdc10 mutant
(cdc10-M17) to synchronize GFP-xlf1 cultures in G1. A phos-
pho-Xlf1 species was not detectable in G1-arrested cells (Fig-
ure 1F); however, upon release from the arrest, phosphorylated
Xlf1 appeared and increased after 120 min, as cells entered G2
phase. These data indicate that Cdc2Cdk1 phosphorylates Xlf1
in a cell-cycle-dependent manner.
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Figure 1. Xlf1 Is Phosphorylated by Cdk1
(A) Alignment of the C-terminal portion of four
fission yeast xlf1 homologs (S. pombe, S. octo-
sporus, S. cryophilus, and S. japonicus), displaying
two conserved cdc2cdk1 phosphorylation motifs
(yellow boxes): [ST]Px[KR].
(B) In vitro Cdk1 kinase assay. Recombinant Xlf1
protein was incubated with mammalian Cdk1 in the
presence of g-32P-ATP and analyzed by autoradi-
ography. Proteins used were the Cdk1 substrate
histone H1 (positive control, 32 kDa), wild-type Xlf1
(27 kDa), single mutations of T180A and S192A,
and double mutations T180A.S192A (AA). Recom-
binant Xlf1 is susceptible to cleavage between
T180 and S192, and the cleavage product (indi-
cated by an asterisk) is visible in the Coomassie-
stained loading control.
(C) In vitro kinase assay using S. pombe Cdc2.
Kinase assay with recombinant protein was con-
ducted as in (B), except using Cdc2 complex pu-
rified from S. pombe cells.
(D) In vivo phosphorylation of Xlf1. GFP-tagged Xlf1
was immunoprecipitated from cell extracts of wild-
type and xlf1.T180A.S192A (xlf1.AA), treated or
mock treated with lambda phosphatase, and
separated by SDS-PAGE in the presence of the
phosphate-binding retardant Phos-tag. Phosphor-
ylated Xlf1 is indicated by an arrow.
(E) GFP-tagged wild-type Xlf1 was immunoprecipated from cells containing the Shokat active site mutation cdc2.F84G (Dischinger et al., 2008) that had either
been treated or mock treated with the inhibitor 1NM-PP1. Immunoprecipitates were treated or mock treated with lambda phosphatase and analyzed by SDS-
PAGE and immunoblotting in either the presence or the absence of Phos-tag.
(F) A temperature-sensitive mutation was used to block cdc10-M17 nmt41-GFP.xlf1 cells in G1 phase and then released into the cell cycle. Phosphorylation of
GFP-Xlf1 was analyzed by SDS-PAGE and immunoblotting of cell extracts in the presence or absence of Phos-tag. A nonspecific band detected by the GFP
antibody is indicated by an asterisk.
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Xlf1 Phosphorylation by Cdc2Cdk1 Alters the Repair of
DSBs by NHEJ
As NHEJ is most active in G1 but inhibited in S/G2 (Ferreira and
Cooper, 2004), we predicted that Xlf1 phosphorylation inhibits
NHEJ. To test this hypothesis, we examined the ability of xlf1
phosphorylation mutants to religate linearized plasmid DNA
(Manolis et al., 2001). Leucine auxotrophic cells were trans-
formedwith linearized plasmid DNA containing the LEU2marker.
Their ability to religate ends and form colonies on selective plates
lacking leucine was assessed by comparison to cells trans-
formed with uncut plasmid. Log-phase cultures in which
Cdc2Cdk1 phosphorylation of Xlf1 had been abolished (xlf1.AA0)
displayed a 2.5-fold increase in end-joining compared to WT
cells (Figure 2A). In contrast, the Xlf1 phosphomimetic mutant
xlf1.EE showed a moderate decrease in plasmid end-joining.
The religation levels were unaffected by the nature of the ends
(blunt or overhangs) in xlf1 mutants. These results indicated
that an inability to phosphorylate Xlf1 leads to increased NHEJ
activity and supports the hypothesis that Cdc2Cdk1 phosphoryla-
tion of Xlf1 inhibits NHEJ.
The resection of DSBs is thought to make them unsuitable for
end-joining. Therefore, we asked if we could increase levels of
end-joining of linearized plasmids by impairing the resection
of DNA ends. We repeated the plasmid religation assays in a
strain lacking the resection gene ctp1+. Deleting ctp1 had no
effect on plasmid religation levels (Figure 2B), suggesting
that preventing Ctp1-dependent resection did not channel
plasmid DSBs into NHEJ. However, when ctp1+ was deleted
in xlf1.AA cells, end-joining levels increased >4-fold compared
to WT levels, significantly above an z2-fold increase caused
by xlf1.AA in the presence of functional Ctp1. This finding
suggested that, in log-phase cells, Ctp1 and phosphory-
lated Xlf1 synergistically counteract end-joining of linearized
plasmid DNA.
Xlf1.AA Slows Down Cellular Responses to DSBs
Next, we characterized cellular response to ionizing radiation
(IR)-induced DSBs in Xlf1 phospho-null strains. A key event in
the cellular response to DNA damage is the activation of DNA
damage checkpoints that arrest progress in the cell cycle to
ensure that DSBs can be repaired. We monitored the phosphor-
ylation status of Chk1 kinase, a marker of G2 checkpoint
activation (Walworth and Bernards, 1996), in response to IR.
IR-induced Chk1 phosphorylation was observed in nmt41-
xlf1.AA chk1-HA cultures at all IR doses, with no discernible
difference to WT chk1-HA cultures (Figure 2C). We also charac-
terized the kinetics of the checkpoint response. In chk1-HA cells,
Chk1 phosphorylation reached a maximum value within 10 min.
In contrast, the phospho-Chk1 band did not appear until 10 min
after irradiation, rising further at later time points. This obser-
vation suggests that nonphosphorylatable Xlf1 causes a decel-
eration of the checkpoint response, though full induction of the
G2 checkpoint, as measured by Chk1 phosphorylation, is still
achieved within 30 min.
Next, we studied the processing of IR-induced DSBs. Rad52
foci form after strand resection has begun and channeled into
recombination processes (Symington and Gautier, 2011). In
order to study the possible interference of phospho-null Xlf1 on
such processes, we analyzed Rad52-GFP foci formed in live cells
following IR. We irradiated rad52-GFP and nmt41-xlf1.AA rad52-
GFPcellswith50Gyandmonitored the formationandpersistence
of Rad52-GFP foci using live-cell imaging. While Rad52 foci were
observed in most cells with both WT xlf1 and nmt41-xlf1.AA, foci
formationwasslower innmt41-xlf1.AA (Figure2D).Rad52 foci for-
mation peaked30min after IR inWT cells but 40–70min after IR
in nmt41-xlf1.AA, in which Rad52 foci also persisted for longer.
This observation is consistent with HR processes, including
DSB resection, being slowed in nmt41-xlf1.AA cells. We did not
observe a general decrease of Rad52 foci in nmt41-xlf1.AA. As
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Figure 2. Phospho-Null xlf1 Increases DNA
End-Ligation Activity and Attenuates Dam-
age Responses
(A) Religation of linearized plasmids containing
blunt ends, 30 and 50 overhangs. Leu+ selection
used to monitor religated plasmids. Data are re-
ported as the mean ± 95% confidence interval.
(B) Religation of linearized plasmids with hygrom-
ycin selection within 2 hr of electroporation. Data
are reported as the mean ± 95% confidence
interval.
(C) Chk1-HA phosphorylation in response to
ionizing radiation was monitored in wild-type and
nmt41-xlf1.AA cells. Cells irradiated with 50 Gy,
100 Gy, and 200 Gy were analyzed 30 min
after irradiation. To characterize the kinetics of
the checkpoint response, cells irradiated with
50 Gy were also analyzed at 3.5 min, 7 min, and
10 min after irradiation. Phosphorylated Chk1 is
indicated.
(D) The formation and persistence of Rad52-GFP
foci following 50 Gy irradiation were monitored in
wild-type and nmt41-xlf1.AA cells.
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Rad52 foci are associated with resection, and as resected DSBs
are not a suitable substrate for NHEJ, the observed deceleration
ofHR isunlikely tobe the result of theoverall balanceofDSBrepair
pathways being tipped in favor of NHEJ.
Overexpression of Xlf1.AA Sensitizes Cells to DNA
Damage
As the balance between HR and NHEJ is tightly regulated in the
cell cycle, we next asked if deregulation of repair pathways re-
sulted in altered sensitivity to DNA damage. To address this
question, we characterized the IR sensitivity of Xlf1 phosphomu-
tants in a stationary state, not requiring cell cycle regulation.
Spores from homozygous crosses of xlf1.AA displayed an IR
sensitivity similar to that of WT spores, in contrast to a small but
reproducible increase in IR sensitivity with xlf1.EE spores (Fig-
ure S1). This suggests that NHEJ is active but can be attenuated,
as observed in the phosphomimetic xlf1 mutant. Similarly,
while deletion of ctp1 increased IR sensitivity of spores, there
was a small but reproducible increase in radioresistance in
xlf1.AA ctp1d, whereas the opposite effect was evident with
xlf1.EE ctp1d spores (Figure S1). The IR sensitivity of ctp1d
spores may be due to damage other than DSBs induced in the
spore state, such as single-strand breaks and other lesions
impeding the first round of replication following germination.
Overexpression of WT xlf1 and xlf1.AA from nmt41 increased
the IR resistance in spores above WT levels. This is again
compatible with the notion that Xlf1 is a limiting factor regulating
NHEJ levels.
In contrast to spores,mutationof theXlf1 phosphorylation sites
did not have a discernible effect on the sensitivity of vegetative
cells to a range of DNA damage treatments (data not shown).
However, overexpression using the medium-level nmt41 pro-
moter of Xlf1 in vegetative cells rendered nmt41-xlf1.AA cells
mildly sensitive to a variety of DNA-damaging agents, such as
camptothecin, tert-butyl hydroperoxide, phleomycin, andmethyl
methanesulfonate in comparison to nmt1-xlf1 (WT) (Figure S1).
The sensitivity was increased in nm41-xlf1.AA. No increase
in xlf1.AA DNA damage sensitivity was observed in strains
in which rad50 had been deleted (Figure S1), revealing an
epistatic relationship with rad50. In addition, we noted that
high-level overexpression from the nmt1 promoter of xlf1.AA,
but not with WT xlf1, caused cells to become inviable (Figures
S1 and S2).
NHEJ Is Hyperactivated in an Xlf1 Cdk1 Phosphorylation
Null Mutant
As plasmid religation assays have relaxed requirements for
NHEJ (Almeida and Godinho Ferreira, 2013), we sought another
in vivo assay to study the role of Xlf1 phosphorylation by
Cdc2Cdk1 on chromosomal DSBs. Chromosome end fusions
can be generated by NHEJ in cells with unprotected telomeres,
such as taz1d (Ferreira and Cooper, 2004). However, chromo-
some end fusions are only generated if taz1d cells are arrested
in G1 but not during S/G2, because of the downregulation of
NHEJ activity in S/G2 phases. If cell cycle inhibition of NHEJ ac-
tivity restricts taz1d chromosome fusions to G1 phase, disinhibi-
tion of NHEJ should lead to chromosome fusions in S/G2-phase
taz1d cells. Therefore, taz1d strains provide a suitable assay to
study the potential inhibitory effect of Xlf1 phosphorylation on
NHEJ in vivo. We first compared G1-arrested (nitrogen-starved)
and S/G2 (log-phase) cultures in which telomeres were unpro-
tected due to taz1+ deletion. Chromosome fusions were de-
tected in taz1d cells in G1 but not in S/G2 cells (Figure 3A).
In contrast, no fusions appeared in G1-arrested taz1d xlf1d
cells, because of downregulation of NHEJ, as expected. Chro-
mosome fusions were also observed in taz1d xlf1.AA cells
when arrested in G1 phase, showing that mutation of the phos-
phorylation sites preserves the ability to carry out NHEJ. It is
important to note, however, that fusions were not detected in
taz1d xlf1.AA during S/G2 phases. Thus, contrary to our predic-
tion, disinhibition of NHEJ by preventing Xlf1 phosphorylation
is not sufficient to fuse unprotected chromosome ends in log-
phase cultures.
NHEJ and HR are regulated independently in the fission yeast
cell cycle, as inactivation of HR does not lead to increased use of
NHEJ in G2 cells (Ferreira and Cooper, 2004). Conversely, we ex-
pected that abnormal activation of NHEJ in G2 cells will take
place in the presence of activated HR, since the disinhibition of
NHEJ alone in the xlf1.AA mutant would not affect HR activity.
Therefore, we reasoned that competition for DSBs between
NHEJ and HR is likely taking place in taz1d xlf1.AA cells, poten-
tially masking the disinhibition of NHEJ, which may only become
detectable once HR is inactivated. To test this hypothesis, we
repeated the experiment in a background in which ctp1 was
deleted. Ctp1 is essential for the initiation of resection, targeting
DSBs toward HR (Limbo et al., 2007). When the chromosome
fusion assays were repeated, no chromosome fusions were
detected in ctp1d taz1d xlf1+ during S/G2 phases (Figure 3B),
establishing that inactivation of Ctp1-dependent resection alone
is not sufficient to cause fusion of unprotected chromosome
ends. Strikingly, inactivation of HR in ctp1d taz1d xlf1.AA cells
led to substantial telomere fusions. We analyzed seven indepen-
dent clones (Figure S3A) and found that all contained intra-
and/or interchromosomal end fusions, including clones with
circular chromosomes (both termini of a chromosome are fused)
during S/G2 phases, a striking effect of NHEJ activity as
confirmed by its absence in the corresponding lig4d strain (Fig-
ure S3B). This indicates that xlf1.AA prevents the inhibition of
NHEJ in G2 cells when HR is inactivated. In contrast, no chromo-
some fusions were detected in the corresponding phosphomi-
micking xlf1 mutant, ctp1d taz1d xlf1.EE. These observations
support the hypothesis that Cdc2Cdk1 phosphorylation of Xlf1
switches off NHEJ during the cell cycle.
To further explore the nature of competition between HR and
NHEJ when both DSB repair pathways are active in the xlf1.AA
phospho-null mutant, we speculated that overexpression of
xlf1+ may overcome the requirement to inactivate HR. We
constructed taz1d strains in which xlf1+ is controlled by the me-
dium-strength nmt41 promoter integrated at the xlf1+ locus.
Chromosome fusions could be detected in log-phase nmt41-
xlf1.AA taz1d cells, even though HR was functional (Figure 3C).
Overexpression of WT xlf1+ similarly caused telomere fusions
in the presence of HR function, though to a lesser extent than
in the phospho-null mutant. This suggests that xlf1+ overexpres-
sion contributes to overcoming recombinogenic mechanisms
that prevent chromosome fusions, tipping the HR/NHEJ balance
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in favor of end-joining, either by promoting NHEJ before DSB
becomes subject to HR or by separately inhibiting HR. These ob-
servations imply that xlf1 is an important regulator in the balance
of HR versus NHEJ during the cell cycle.
Xlf1.AA Affects Both HR and NHEJ of Linearized
Plasmid DNA
The observation that chromosome end ligations (taz1d cells) in
the xlf1.AA phosphomutant require inactivation of HR indicates
crosstalk between NHEJ and HR. To verify if a similar effect
could be identified in the processing of plasmid DNA ends by
the two DSB repair pathways, we designed an assay in which
the levels of HR and NHEJ can be assessed in parallel. Cells
were electroporated with two different linearized plasmids.
One plasmid, containing WT leu1+ but no ARS, could be inte-
grated at the leu1-32 locus via an HR-dependent mechanism,
giving rise to Leu+ colonies. The second plasmid, containing
the antibiotic resistance gene hphR and an S. pombe ARS, could
be recircularized by NHEJ and stably maintained, giving rise
to hygromycin-resistant colonies. Hygromycin selection was
applied after 2 hr. Cells were transformed in parallel; the fre-
quency of leu1+ colonies and hygromycin-resistant colonies
were determined in relation to an uncut plasmid control as a
measure of HR and NHEJ activity, respectively. Deletion of
xlf1+ decreased plasmid religation50 fold (Figure 3D), whereas
deletion of ctp1+ decreased plasmid integration 50 fold, indic-
ative of inactivation of NHEJ and HR, respectively. Deletion of
xlf1+ or lig4+ also caused a small but reproducible decrease in
HR-dependent plasmid integration. Plasmid religation was
increased in xlf1.AA mutant cells, though less than in the assay
used in Figure 3D, presumably because of the much-reduced
time available for religation with antibiotic rather than auxotro-
phic selection. Unexpectedly, plasmid integration was reduced
by two-thirds in xlf1.AA (endogenous promoter), suggesting
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Figure 3. xlf1.AA Promotes NHEJ Fusion of Unprotected Telomeres
(A) Ligation of chromosome ends in xlf1 mutants in taz1d strains. Scheme of telomeric NotI restriction fragments. Chromosomes I and II each release two
telomeric restriction fragments (C, I, L, andM). Chromosome III lacks NotI restriction sites; NotI digests of genomic DNAof the indicated strains were separated by
PFGE, and chromosomal end-to-end fusions were detected by Southern blotting with a telomere probe (arrows indicate positions of resolved telomere fusions).
Nitrogen-starved taz1d used as positive control for fusions.
(B) PFGE analysis reveals that Xlf1.AA promotes NHEJ-mediated telomeric fusions in cycling cells in taz1d ctp1d background.
(C) Xlf1 overexpression is sufficient to promote telomeric fusions in taz1d cycling cells, and xlf1.AA mutation increases the amount of these fusions. Ligation of
chromosome ends in taz1d strains overexpressing xlf1mutants from the nmt41 promoter was analyzed by PFGE. taz1+ control strains contain the same amount
of DNA, though the signal from the telomeric probe is weaker as a result of telomere elongation in taz1d.
(D) Assaying for NHEJ and HR activities in parallel, using hygromycin resistance and leu1 integration of linearized plasmid fragments. Data are reported as the
mean ± 95% confidence interval.
See also Figure S3C.
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that disabling the phosphorylation of Xlf1 leads to inhibition of
HR. In addition, while deletion of ctp1+ by itself had no significant
impact on NHEJ, deletion of ctp1+ in an xlf1.AA mutant led to a
much larger increase in plasmid religation than in HR-competent
xlf1.AA. Together, these observations provide further evidence
that phospho-null xlf1.AA affects the levels of HR.
Cell cycle regulation of DSB repair pathway selection by Cdk1
was first established with the discovery that DSB resection re-
quires Cdk1 activity (Aylon et al., 2004; Ira et al., 2004). However,
while Cdk1 has been shown to control the function of several HR
factors, a reciprocal regulation of NHEJ byCdk1 has not been re-
ported. While budding yeast Ku70 and Ku80 contain several po-
tential Cdk1 phosphorylation sites, their mutation does not affect
NHEJ activity (Zhang et al., 2009). Moreover, the dependence of
resection for Cdk1 activity can be overcome by the deletion
of Ku, suggesting an indirect control over NHEJ by modulation
of HR (Clerici et al., 2008). Nej1, the budding yeast XLF homolog,
was discovered as a factor downregulating NHEJ in diploid cells
(Frank-Vaillant and Marcand, 2001; Kegel et al., 2001; Valencia
et al., 2001). Lif1, the S. cerevisiae XRCC4 homolog, has been
found to be phosphorylated by Cdk1, but this phosphorylation
has little effect on the levels of classical NHEJ and, instead,
affects a Sae2ctp1-dependent resection-mediated imprecise
joining pathway (Matsuzaki et al., 2012). Our study shows that
Cdk1 phosphorylation of a core NHEJ factor directly regulates
classical NHEJ during the cell cycle. We show that Xlf1 becomes
phosphorylated by Cdc2Cdk1 on T180 and S192 and that the
levels of phosphorylation increase through the cell cycle as
Cdc2Cdk1 activity increases. These results establish that phos-
phorylation of Xlf1 has an inhibitory effect, as there is a reduction
in the levels of religation of linearized DNA with the phosphomi-
mic xlf1.EE but an increase with the phospho-null xlf1.AA
mutant. Together, these observations allow us to propose a
model in which Xlf1 functions as a cellular switch for NHEJ (Fig-
Figure 4. Model of Cdk1 Regulation of the
Balance between NHEJ and HR
The activity of CDK1 is a major determinant of DSB
repair pathway choice. When CDK1 is low, non-
phosphorylated Xlf1 exists in the cell and NHEJ is
fully active. As CDK1 activity rises, phosphorylation
of Xlf1 increases, leading to the inactivation of
NHEJ. The phosphorylation of CDK1 targets in the
HR pathway leads to the activation of HR.
ure 4), with nonphosphorylated Xlf1 repre-
senting the on state (NHEJ active) and
phosphorylated Xlf1 representing the off
state (NHEJ inactive). The NHEJ repair
pathway is fully active in G1, but as cells
advance in the cell cycle, Cdc2Cdk1 levels
rise and Xlf1 becomes increasingly
phosphorylated, leading to inactivation
of end-joining. Although this report estab-
lishes that Xlf1 is an important NHEJ
regulator, further studies are required to
establish how Cdk1 phosphorylation of
this factor restrains NHEJ in cycling cells
and whether this key regulatory function is also conserved in
other eukaryotic organisms.
EXPERIMENTAL PROCEDURES
Standard methods used for strain construction, western blotting, and micro-
scopy are detailed in the Supplemental Experimental Procedures. Strains
used are listed in Table S1.
Phosphatase Treatment of nmt41-GFP-Tagged Xlf1
A total of 109 log-phase cells grown without thiamine was resuspended in lysis
buffer (50 mM Na phosphate [pH 7], 150 mM NaCl, 50 mM NaF, 10 mM EDTA,
10% glycerol, 0.5% NP40, Roche protease inhibitor) and broken with glass
beads. Cleared lysate containing 15 mg total protein was incubated for 2 hr
at 4Cwith 15 ml GFP-Trap Amagnetic beads (Chromotek) per immunoprecip-
itation. Beads were washed with lysis buffer, washed three times in PMP buffer
(New England Biolabs; NEB) plus MnCl2, resuspended in 100 ml, divided into
two, and either mock treated or incubated with 800 units of lambda phospha-
tase (NEB) at 30C for 30 min. Beads were resuspended in Laemmli buffer and
boiled. Samples were separated by SDS-PAGE on 12% gels containing 25 mM
Phos-tag (AAL-107 Wako) and 50 mM MnCl2. Prior to transfer onto polyvinyli-
dene fluoride, gels were incubated for 10min in transfer buffer with 1mMEDTA
and then without EDTA. GFP-Xlf1 was detected using anti-GFP antibody
(Invitrogen, 1:2,500 dilution).
In Vitro Cdc2Cdk1 Kinase Assay
Active Cdc2 enzyme was isolated from a lysate of 53 108 WT S. pombe cells
resuspended in 400 ml of HB buffer (25 mM Tris [pH 7.5], 15 mM EGTA, 15 mM
MgCl2, 0.1% NP40, protease inhibitor cocktail) broken using glass beads.
Per kinase reaction, cell lysate containing 1mg total cellular protein wasmixed
with 40 ml of p13suc1 agarose conjugate (Millipore), incubated with rotation at
4C for 3 hr, washed three times with HB buffer, and then washed once with
kinase buffer (10 mM HEPES [pH 7.5], 75 mM KCl, 5 mM MgCl2, 1 mM dithio-
threitol). For each kinase assay reaction, beads were then mixed in a total
volume of 15 ml containing 1.5 mg purified protein (either recombinant
6His-Xlf1 or histone H1), 20 mM ATP, and 5mCi g-32P-ATP, all diluted in kinase
buffer. The same method was used with Cdk1 (NEB). The kinase reaction was
allowed to proceed for 10 min at room temperature and then was stopped
by adding SDS-PAGE loading buffer and heated to 90C for 5 min. Protein
2016 Cell Reports 9, 2011–2017, December 24, 2014 ª2014 The Authors
was separated on 15% gels and subjected to Coomassie staining and
autoradiography.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.11.044.
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Supplemental Table 1: strains used  
 
Name genotype 
PH111 xlf1:: natMX-nmt41-GFP-xlf1::loxP/M 
PH113 xlf1:: natMX-nmt41-GFP-xlf1.T180A.S192A::loxP/M 
PH369 cdc2.F84G xlf1:: natMX-nmt41-GFP-xlf1::loxP/M 
PH371 cdc2.F84G xlf1:: natMX-nmt41-GFP-xlf1.T180A.S192A::loxP/M 
PH365 cdc10.M17 xlf1:: natMX-nmt41-GFP-xlf1::loxP/M 
PH360 cdc10.M17 xlf1:: natMX-nmt41-GFP-xlf1.T180A.S192A::loxP/M 
PH001 ura4D-18 leu1-32 nmt41-xlf1::natMX 
PH095 ade6-704 leu1-32 ura4-D18 xlf1::xlf1::loxP/M 
PH097 ade6-704 leu1-32 ura4-D18 xlf1::xlf1. T180A.S192A::loxP/M 
PH099 ade6-704 leu1-32 ura4-D18 xlf1::xlf1. T180E.S192E::loxP/M 
MGF490 ade6-704 leu1-32 ura4-D18 taz1::natMX xlf1::ura4::loxP/M 
MGF491 ade6-704 leu1-32 ura4-D18 xlf1::xlf1::loxP/M taz1::kan 
MGF492 ade6-704 leu1-32 ura4-D18 xlf1.T180A.S192A::loxP/M taz1::kan 
MGF493 ade6-704 leu1-32 ura4-D18 xlf1.T180E.S192E::loxP/M taz1::kan 
MGF633 ade6-704 leu1-32 ura4-D18 xlf1.T180E.S192E::loxP/M xlf1EE ctp1::KanR 
taz1::URA4+  
MGF669 leu1-32 ura4-D18  xlf1.T180A.S192A::loxP/M ctp1::KanR taz1::URA4+ 
MGF672 ura4D-18 leu1-32 nmt41-xlf1::natMX  taz1::URA4+ 
MGF673 ura4D-18 leu1-32 nmt41-xlf1.AA::natMX  taz1::URA4+  
MGF1776 ade6-704 leu1-32 ura4-D18 xlf1.T180A.S192A::loxP/M taz1::kan lig4::natMX 
ctp1::hphMX  
 
Table of the strains used and their genotypes. Related to Experimental Procedures. 
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Supplemental Figure Legends 
Figure S1 related to Figure 1 
A. Spore survival of spores deleted for ctp1 
B. Spore survival of xlf1 point mutants 
C. Spot tests with DNA damage treatment of strains overexpressing xlf1 from medium-
level nmt41 
D. Spot tests with DNA damage treatment of xlf1 mutants overexpressing from medium-
level nmt41 and high-level nmt1 
E. Spot tests with DNA damage treatment of xlf1 overexpression in rad50 deletion 
background 
 
Thiamine 25nM 
wild-type 
nmt1-xlf1 
nmt1-xlf1.AA  
wild-type 
nmt1-xlf1 
nmt1-xlf1.AA  
wild-type 
nmt1-xlf1 
nmt1-xlf1.AA  
Thiamine 0.78nM 
No Thiamine 
rad50d 
rad50d nmt1-xlf1 
rad50d nmt1-AA  
rad50d 
rad50d nmt1-xlf1 
rad50d nmt1-AA  
rad50d 
rad50d nmt1-xlf1 
rad50d nmt1-AA  
Thiamine 25nM 
Thiamine 0.78nM 
No Thiamine 
A                             B 
Figure S2 
Figure S2 related to Figure 2 
A. Spot test with nmt1 high-level overexpression of xlf1 mutants. 
B. Spot test with nmt1 high-level overexpression of xlf1 mutants in rad50d background. 
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Figure S3 related to Figure 3 
A. 7 independent clones were isolated by deleting taz1 in ctp1d xlf1.AA cells through 
integration of a kanMX antibiotic resistance cassette. xlf1.AA is expressed at endogenous 
levels. 
Diagram of telomeric NotI restriction fragments. Chromosomes I and II each release two 
telomeric restriction fragments (C, I, L and M). Chromosome III lacks NotI restriction sites; 
NotI digests of genomic DNA of the indicated strains were separated by PFGE and 
chromosomal end‐to‐end fusions were detected by Southern blot using a telomere probe 
(arrows indicate the positions of the resolved telomere fusions). Nitrogen starved taz1d 
was used as positive control for fusions. 
B. NHEJ‐mediated telomeric fusions in cycling cells of two independent clones of ctp1d 
taz1d xlf1.AA and two independent clones of ctp1d taz1d lig4d xlf1.AA. PFGE analysis and 
Southern blot using a using a telomere probe.  
C. Southern blot (top) and ethidium bromide stained agarose gel (bottom) of PFGE shown 
in Fig 3. Decreases in the signal intensity from the telomere probe are not due to less DNA 
being loaded. Wild-type xlf1 and xlf1.AA are expressed from the medium-strength 
thiamine-derepressible nmt41 promoter. 
Experimental Procedures 
 
Genetic and Cell Studies 
Media and standard genetic techniques were as described previously (Moreno et al., 1991). 
Spot tests and spore survival assays were carried out as in (Hentges et al., 2006) xlf1 
phosphorylation mutant strains were created by integrating DNA fragments containing 
T180A.S192A and T180E.S192E at the xlf1 locus using a cre-lox method described in 
(Watson et al., 2008). nmt41, nmt1 and nmt41-GFP strains were derived from this by 
integrating the corresponding cassettes described in (Van Driessche et al., 2005). Nat 
deletion strains were constructed as in (Hentges et al., 2005). For the taz1d assays, 
strains were created by integrating a kanMX cassette into the relevant background at the 
taz1 locus while assays was carried out as described previously (Reis et al., 2012).  
 
To determine the formation of Rad52 foci after IR, nmt1-xlf1 rad52-GFP and nmt1-xlf1.AA 
rad52-GFP cells were grown to log-phase in YNB without thiamine. A population of early 
G2 cells was isolated using centrifugation through a lactose gradient. Cells were treated 
with 50Gy gamma irradiation, attached to a concanavalin A-coated chamber. The 
presence of Rad52 foci was monitored over 4 hours. 
 
DSB Plasmid Repair Assays 
The plasmid religation assay using leucine selection (fig 2.a) was carried out as described 
previously (Manolis et al., 2001). The plasmid relegation assay using hygromycin selection 
(fig 2.b) was carried out in the same manner except that plasmid pRL1 bearing a hphMX 
marker was used, and that plasmid transformation was followed by a 2 hour incubation 
step before hygromycin selection was applied by plating cells on hygromcyin-containing 
media. The plasmid repair assay measuring HR and NHEJ in parallel (fig. 3.d) used 
plasmids pRL1 (hygromycin) for end-joining and pJK148 (leu1 marker) for chromosomal 
integration at leu1. 2x108 mid-log phase cells were washed and incubated in 4ml DTT 
buffer for 15min at 30°C. Cells were washed twice with 2ml 1M sorbitol, resuspended in a 
total volume of 100µl by adding 70µl 1M sorbitol and then divided in two. For the NHEJ 
electroporations, 200ng uncut pAL19 and 600ng EcoRV and PvuII digested pRL1 plasmid. 
For the HR electroporations add 600ng uncut pRL1 and 400ng NdeI digested pJK148 
plasmid DNA. Cells were then transferred to pre chilled electroporation cuvettes (0.2cm), 
electroporated at 1500V, 200Ω, 25µF. 950µL ice cold YNB with 1M sorbitol was added 
immediately and cells were incubated at 30°C for 2 hours. Cells were then plated on 
selective plates (YNB +ura +ade -leu, YEA +hyg) and incubated at 30°C for 4-5 days. 
NHEJ efficiency was calculated by dividing the number of hygromycin resistant colonies by 
the number of leucine positive colonies. HR efficiency was calculated by dividing leu+ 
colonies by the number of hygromycin resistant colonies. Values were normalised to wt = 
100% for both repair pathways. 
 
Protein methods 
To separate and detect phosphorylated Xlf1 using the Phos-tag, samples were separated 
by SDS-PAGE on 12% gels containing 25μM Phos-tag (AAL-107 Wako) and 50μM MnCl2. 
Prior to transfer onto PVDF, gels were incubated for 10min in transfer buffer with 1mM 
EDTA, then buffer without EDTA, followed by standard Western blotting. GFP-Xlf1 was 
detected using anti-GFP antibody from Invitrogen (1:2500 dilution).  
 
For the experiment with cdc10.M17 ts cells, cultures were grown to log-phase in EMM2 
without thiamine at 25°C, blocked by growth at 36.5°C for one generation time, and 
released by switching temperature to 25°C. Whole cell lysates were prepared using the 
TCA method (Watson et al., 2008) and analysed by Western blotting with Phos-tag as 
described above. 
 
Chk1 phosphorylation was analysed using lysates prepared using the TCA method, and 
detection of Chk1-HA using monoclonal anti-HA antibody (diluted 1:2000; Santa Cruz 
Biotechnology). 
 
Recombinant Xlf1 protein with the mutations T180A, S192A, or T180A.S192A was 
prepared by site-directed mutagenesis of xlf1 on pET28a, followed by expression and 
purification as described previously (Hentges et al., 2006).  
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